Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2005
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2567190A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
12/01/2005CA2566445A1 Methods related to the treatment of neurodegenerative and inflammatory conditions
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005CA2565029A1 Immediate release pharmaceutical tablets with height greater than width
12/01/2005CA2563968A1 Neurogenic pain control agent composition
11/2005
11/30/2005EP1600445A1 Medicinal composition
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600180A2 Antiproliferative drug and delivery device
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1600154A1 Osmotic extended-release dosage form
11/30/2005EP1599432A1 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005EP1599199A2 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist
11/30/2005EP1599175A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
11/30/2005EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides
11/30/2005EP1313697B1 Immunoregulatory compounds, derivatives thereof and their use
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1267831B1 New self emulsifying drug delivery system
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP1224185B1 Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703402A Pyridine derivatives as CB2 receptor modulators
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703234A The use of low-molecular-weight thrombin inhibitor
11/30/2005CN1703226A Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol
11/30/2005CN1703218A Combinations of benzodithiazoles and COx-2 inhibitors for the treatment of pain
11/30/2005CN1703203A Organoleptically acceptable intraorally disintegrating compositions
11/30/2005CN1703199A Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug
11/30/2005CN1701792A Preparation for external use on skin
11/30/2005CN1701791A Medicine for treating allergic skin disease and its preparation process
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229339C Compounds inhibiting angiogenesis and tumor growth, pharmaceutical preparation containing same and pharmaceutical use thereof
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/30/2005CN1229134C External Chinese patent medicines for curing periarthritis humeroscapularis and myotenositis
11/30/2005CN1229126C Chinese medicine for curing rheumatoid arthritis
11/30/2005CN1229120C Carthamus flower medicated liquor
11/30/2005CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/28/2005CA2508093A1 Preparation for external use on skin
11/24/2005WO2005111037A1 Beta-carbolines useful for treating inflammatory disease
11/24/2005WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
11/24/2005WO2005110451A1 Coffee bean extract, extraction method and composition containing the extract
11/24/2005WO2005110450A1 Medicinal composition and therapeutic method
11/24/2005WO2005110002A2 Anti-inflammatory and anticeptic suppository exhibiting a regeneration effect
11/24/2005US20050261584 Devices and methodologies useful in body aesthetics
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261301 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261288 Tetracyclic lactam derivatives and uses thereof
11/24/2005US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents
11/24/2005US20050261284 Diazinopyrimidines
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050261245 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
11/24/2005US20050261207 Glucose-based compounds with affinity to p-selectin
11/24/2005US20050261197 Coffee bean extract, method of extraction and composition containing the same
11/24/2005US20050261194 Use of thymulin-like peptides for making pain-relieving medicines
11/24/2005US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III
11/24/2005US20050261163 Pharmaceutical products, preparation and uses thereof
11/24/2005US20050261162 Pharmaceutical composition for preventing and treating cancer and treating an inflammation
11/24/2005US20050260767 Treatment with cytokines
11/24/2005US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
11/24/2005US20050260644 Cell signaling proteins
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
11/24/2005US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor
11/24/2005US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor
11/24/2005US20050260290 Botanical anti-inflammatory compositions and methods
11/24/2005US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
11/24/2005US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents
11/24/2005CA2566877A1 Medicinal composition and therapeutic method
11/24/2005CA2566721A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
1 ... 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 ... 1272